| Income statement (USD) | FY 2025 ended Dec 31, 2025 | FY 2024 ended Dec 31, 2024 | FY 2023 ended Dec 31, 2023 | FY 2022 ended Dec 31, 2022 | FY 2021 ended Dec 31, 2021 | FY 2020 ended Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue | 20.38B | 20.10B | 19.46B | 17.97B | 17.42B | 16.47B |
| Cost of revenue | 8.13B | 7.94B | 8.13B | 7.72B | 7.05B | 6.45B |
| Gross profit | 12.25B | 12.16B | 11.33B | 10.25B | 10.38B | 10.02B |
| Research and development | 366.00M | 355.00M | 343.00M | 320.00M | 307.00M | 290.00M |
| Selling, general and admin | 7.90B | 7.73B | 7.15B | 6.57B | 6.41B | 6.02B |
| Operating income | 3.31B | 4.27B | 3.98B | 2.89B | 3.33B | 3.88B |
| EBITDA | 3.94B | 4.87B | 4.55B | 3.44B | 3.89B | 4.42B |
| Interest expense | 267.00M | 292.00M | 287.00M | 167.00M | 120.00M | 184.00M |
| Income before tax | 3.06B | 3.96B | 3.39B | 2.66B | 3.09B | 3.65B |
| Income tax | 798.00M | 907.00M | 937.00M | 693.00M | 749.00M | 787.00M |
| Net income | 2.13B | 2.89B | 2.30B | 1.78B | 2.17B | 2.69B |
| EPS | 2.64 | 3.53 | 2.78 | 2.13 | 2.56 | 3.15 |
| EPS (diluted) | 2.63 | 3.51 | 2.77 | 2.13 | 2.55 | 3.14 |
| Diluted shares | 811.10M | 823.20M | 829.20M | 838.80M | 848.30M | 859.30M |
| Dividends per share | 2.08 | 2.48 | 1.91 | 1.86 | 1.79 | 1.75 |
From Colgate-Palmolive's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.